An ALPINE guide to covalent BTKis in CLL
In this issue of Blood, Brown et al1 present the final comparative analysis of the ALPINE study, comparing zanubrutinib with ibrutinib for patients with re
In this issue of Blood, Brown et al1 present the final comparative analysis of the ALPINE study, comparing zanubrutinib with ibrutinib for patients with re
Researchers say barriers such as time constraints and financial limitations complicate fertility counseling and preservation for patients with lymphoma.
Rates of invasive cancer were noninferior when patients with low-risk ductal carcinoma in situ received active monitoring vs guideline concordant care.
Remarkable advances and remaining questions.
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
2024 Most Read Articles | Blood | American Society of Hematology Top Ten Most Read Articles in 2024 Blood is pleased to announce the following…
Aaron Gerds, MD, discusses differences in molecular targets, efficacy, and toxicity profiles between available JAK inhibitors in myelofibrosis.
Remarkable advances and remaining questions.
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
Orca-Q led to low rates of graft-vs-host disease and non-relapse mortality in high-risk hematologic malignancies undergoing allo-HCT.
Researchers investigated the diagnostic value of assessing serum lipid profiles and insulin resistance markers for gastric cancer.